Filing Flows

Filing Flows › Novo Nordisk A S (NVO) › Next earnings date

Novo Nordisk A S (NVO) earnings: beat the estimate

Novo Nordisk A S (NVO) reported on Nov 4, 2026 and beat the EPS estimate: $5.79 against $4.62 (+25.3%). It beat the EPS estimate in 80% of the quarters on record.

Last result+25.3% vs estimate
Beat rate80%

The last report

Novo Nordisk A S reported revenue of $309.1B for the fiscal 2025 (+6% Y/Y), net earnings $102.4B. How it makes money → · Every quarter →

Novo Nordisk A S: EPS against the estimate, last 5 reportsNovo Nordisk A S: EPS against the estimate, last 5 reportsEstimateReported$4.24$4.50Nov 25$5.90$6.04Feb 26$6.96$6.63May 26$4.98$6.18Aug 26$4.62$5.79Nov 26
Latest (Nov 26): Estimate $4.62, Reported $5.79.
NVO: the stock's move on each reportNVO: the stock's move on each reportAug 4, 2026-5.4%May 6, 2026+2.1%Feb 3, 2026-19.9%Nov 5, 2025-3.6%

Novo Nordisk A S' latest quarter

Novo Nordisk A S, FY2025: revenue $309.1B (+6% year over year), operating margin 41.3%, net earnings $102.4B, operating cash flow $119.1B. The chart follows the revenue to costs, profit and cash.

Questions

Did Novo Nordisk A S beat earnings?

Novo Nordisk A S (NVO) reported on Nov 4, 2026 and beat the EPS estimate: $5.79 against $4.62 (+25.3%).

When does NVO report earnings?

The next date is not set yet.

Does Novo Nordisk A S usually beat earnings?

It beat the consensus EPS estimate in 80% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.